In this issue:
Methotrexate in moderate-to-severe psoriasis
Guselkumab efficacy after withdrawal
Guselkumab vs ustekinumab for moderate-to-severe plaque psoriasis
Tofacitinib in paediatric psoriasis
Machine learning predictors of non-calcified coronary burden
Treatment patterns for ixekizumab vs secukinumab
DLQI Work/Study domain estimation of overall work productivity
Calcipotriene/betamethasone gel in adolescents with scalp and body psoriasis
Review of treatment strategies for erythrodermic psoriasis
Disease burden and patient needs and benefits in anogenital psoriasis
Please login below to download this issue (PDF)